Dr. Alexander Caudarella appointed the new CEO of the Canadian Centre on Substance Use and Addiction (CCSA)
Dr. Alexander Caudarella, MDCM CCFP AM ABAM(d)
To: CEO, Canadian Centre on Substance Use and Addiction
Dr. Alexander Caudarella, a bilingual family physician specializing in substance use issues, has been appointed the new CEO of the Canadian Centre on Substance Use and Addiction (CCSA) effective August 2022.
He received his Doctor of Medicine at McGill University in 2012. His speciality training includes the Research in Addiction Medicine Scholar program and a clinical Fellowship in Addiction Medicine at the University of British Columbia. He is a diplomate of the American Board of Addiction Medicine.
Dr. Caudarella served as the Substance Use Services Medical Director and a Staff Addiction Physician at St. Michael’s Hospital/Unity Health Toronto and with Inner City Health Associates. He is a mental health and substance use consultant for the Government of Nunavut. He is also Clinical Lead for the Centre on Drug Policy Evaluation at the University of Toronto.
Other experience includes being a member of Ontario’s Opioid Emergency Task Force and the COVID-19 Opioid Working Group.
The Canadian Centre on Substance Use and Addiction (CCSA) is a non-partisan and trusted expert on substance use and addiction. CCSA uses evidence-based research and recommendations to bring together governments, organizations and people with disparate voices to help people living in Canada lead healthier, more productive lives.